Chemoprevention in bladder cancer: What's new?
- PMID: 20019982
- PMCID: PMC2792454
- DOI: 10.5489/cuaj.1193
Chemoprevention in bladder cancer: What's new?
Abstract
Bladder cancer is the sixth most common tumour in Canada and ranks eighth in terms of cancer mortality. Up to now, management of this condition relied mostly on surgical and intravesical treatments once the disease is established. Chemoprevention is an attractive option to prevent the disease in high-risk populations and may well reduce the costs related to its treatment. This review examines the available data on chemoprevention strategies in bladder cancer, with special emphasis on randomized controlled trials when available.
References
-
- Ohno Y, Aoki K, Obata K, et al. Case Control Study of Urinary Bladder Cancer in Metropolitan Nagoya. Natl Cancer Inst Monogr. 1985;69:229–34. - PubMed
-
- Lynch CF, Cohen MB. Urinary System. Cancer. 1995;75:316–29. - PubMed
-
- Braver DJ, Modan M, Chêtrit A, et al. Drinking, Micturition Habits, and Urine Concentration as Potential Risk Factors in Urinary Bladder Cancer. J Natl Cancer Inst. 1987;78:437–40. - PubMed
-
- Michaud DS, Spiegelman D, Clinton SK, et al. Fluid Intake and the Risk of Bladder Cancer in Men. N Engl J Med. 1999;340:1390–7. - PubMed
-
- Geoffroy-Perez B, Cordier S. Fluid consumption and the risk of bladder cancer: Results of a multicenter case-control study. Int J Cancer. 2001;93:880–7. - PubMed
LinkOut - more resources
Full Text Sources